FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945596793> ?p ?o ?g. }

• W2945596793 endingPage "228" @default.
• W2945596793 startingPage "228" @default.
• W2945596793 abstract "Cannabis dependence is associated with psychiatric, social, and legal consequences. Currently, there is no approved pharmacological treatment for cannabis dependence. Recent studies have reported the utility of N-acetylcysteine (NAC) and baclofen (BAC) in the long-term treatment of cannabis dependence, primarily as anticraving agents.We reviewed the records of all patients who received inpatient treatment during 2015-2017 for cannabis dependence syndrome. We included cases only if cannabis dependence was noted as the primary focus for seeking inpatient care. Data are collected up to 6 months following discharge and analyzed using Kaplan-Meier survival analysis. The time to the first use of cannabis (in days) following discharge is compared between three groups - psychosocial intervention (PSI) only, BAC in addition to PSI, and NAC in addition to PSI.During the study period, 238 inpatients were diagnosed with cannabis dependence syndrome. However, cannabis dependence was the primary focus of treatment in only 72 patients. Among these patients, 29 (40.2%) received PSI only while 25 (34.8%) received BAC (mean dose = 55 mg per day, standard deviation [SD] = 2.5 mg) and 18 (25%) received NAC (mean dose = 1800 mg per day, SD = 500 mg) in addition to PSI. While 47 (62.5%) of the patients had comorbid psychiatric disorders, it was comparably distributed in the three groups. A survival analysis shows that the probability of cannabis-free survival is significantly higher in the NAC group as compared to the BAC group which is in turn higher than the PSI group (χ2 = 12.1, P = 0.002).The use of anticraving medications, namely BAC and NAC, may be a useful option along with PSIs in patients with cannabis dependence and requires further exploration." @default.
• W2945596793 created "2019-05-29" @default.
• W2945596793 creator A5014032852 @default.
• W2945596793 creator A5024019697 @default.
• W2945596793 creator A5051044911 @default.
• W2945596793 creator A5069096470 @default.
• W2945596793 creator A5078955804 @default.
• W2945596793 date "2019-01-01" @default.
• W2945596793 modified "2023-09-24" @default.
• W2945596793 title "Relative effectiveness of N-acetylcysteine and baclofen as anticraving agents in cannabis dependence – A retrospective study with telephonic follow-up" @default.
• W2945596793 cites W1708796529 @default.
• W2945596793 cites W1971398808 @default.
• W2945596793 cites W1997016233 @default.
• W2945596793 cites W2050726985 @default.
• W2945596793 cites W2121945096 @default.
• W2945596793 cites W2151735632 @default.
• W2945596793 cites W2169785468 @default.
• W2945596793 cites W2170979974 @default.
• W2945596793 cites W2414702405 @default.
• W2945596793 cites W2491859250 @default.
• W2945596793 cites W2624100118 @default.
• W2945596793 cites W4211088954 @default.
• W2945596793 doi "https://doi.org/10.4103/psychiatry.indianjpsychiatry_16_19" @default.
• W2945596793 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6532463" @default.
• W2945596793 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31142898" @default.
• W2945596793 hasPublicationYear "2019" @default.
• W2945596793 type Work @default.
• W2945596793 sameAs 2945596793 @default.
• W2945596793 citedByCount "2" @default.
• W2945596793 countsByYear W29455967932020 @default.
• W2945596793 countsByYear W29455967932022 @default.
• W2945596793 crossrefType "journal-article" @default.
• W2945596793 hasAuthorship W2945596793A5014032852 @default.
• W2945596793 hasAuthorship W2945596793A5024019697 @default.
• W2945596793 hasAuthorship W2945596793A5051044911 @default.
• W2945596793 hasAuthorship W2945596793A5069096470 @default.
• W2945596793 hasAuthorship W2945596793A5078955804 @default.
• W2945596793 hasBestOaLocation W29455967931 @default.
• W2945596793 hasConcept C118552586 @default.
• W2945596793 hasConcept C126322002 @default.
• W2945596793 hasConcept C150966472 @default.
• W2945596793 hasConcept C2776895053 @default.
• W2945596793 hasConcept C2777056318 @default.
• W2945596793 hasConcept C2910205722 @default.
• W2945596793 hasConcept C71924100 @default.
• W2945596793 hasConceptScore W2945596793C118552586 @default.
• W2945596793 hasConceptScore W2945596793C126322002 @default.
• W2945596793 hasConceptScore W2945596793C150966472 @default.
• W2945596793 hasConceptScore W2945596793C2776895053 @default.
• W2945596793 hasConceptScore W2945596793C2777056318 @default.
• W2945596793 hasConceptScore W2945596793C2910205722 @default.
• W2945596793 hasConceptScore W2945596793C71924100 @default.
• W2945596793 hasIssue "3" @default.
• W2945596793 hasLocation W29455967931 @default.
• W2945596793 hasLocation W29455967932 @default.
• W2945596793 hasLocation W29455967933 @default.
• W2945596793 hasLocation W29455967934 @default.
• W2945596793 hasOpenAccess W2945596793 @default.
• W2945596793 hasPrimaryLocation W29455967931 @default.
• W2945596793 hasRelatedWork W1756112211 @default.
• W2945596793 hasRelatedWork W1964148535 @default.
• W2945596793 hasRelatedWork W2011983855 @default.
• W2945596793 hasRelatedWork W2021764975 @default.
• W2945596793 hasRelatedWork W2068734838 @default.
• W2945596793 hasRelatedWork W2100061623 @default.
• W2945596793 hasRelatedWork W2104260215 @default.
• W2945596793 hasRelatedWork W2788539666 @default.
• W2945596793 hasRelatedWork W3011979612 @default.
• W2945596793 hasRelatedWork W904282840 @default.
• W2945596793 hasVolume "61" @default.
• W2945596793 isParatext "false" @default.
• W2945596793 isRetracted "false" @default.
• W2945596793 magId "2945596793" @default.
• W2945596793 workType "article" @default.